FDA report claiming Covid vaccine link to children’s deaths misses deadlinenews2026-01-06T20:23:27+00:00January 6th, 2026|Endpoints News|
FDA raises new questions with Sanofi’s MS drug in release of rejection letternews2026-01-05T20:22:17+00:00January 5th, 2026|Endpoints News|
US to stop recommending six vaccines for all kids, prioritizing individual choice and higher-risk groupsnews2026-01-05T19:02:32+00:00January 5th, 2026|Endpoints News|
Zenas BioPharma’s Phase 3 autoimmune disease readout disappointsnews2026-01-05T16:21:59+00:00January 5th, 2026|Endpoints News|
Vanda wins FDA approval for motion sickness drug news2025-12-31T15:47:05+00:00December 31st, 2025|Endpoints News|
FDA rejects Corcept’s cortisol-targeting drug for Cushing’s syndromenews2025-12-31T15:20:26+00:00December 31st, 2025|Endpoints News|
Agios finally wins approval for Aqvesme in thalassemianews2025-12-24T13:03:04+00:00December 24th, 2025|Endpoints News|
Sanofi to buy hepatitis B vaccine maker Dynavax for $2.2B; gets CRL for MS drugnews2025-12-24T12:11:48+00:00December 24th, 2025|Endpoints News|
Drugmakers with White House pricing deals may skirt new Medicare demosnews2025-12-23T18:57:02+00:00December 23rd, 2025|Endpoints News|
Novo Nordisk eyes a strong launch with FDA approval of obesity pillnews2025-12-22T23:54:53+00:00December 22nd, 2025|Endpoints News|
